• About
  • Offices
  • Careers
  • News
  • Students
  • Alumni
  • Payments
  • EN | FR
Background Image
Bennett Jones Logo
  • People
  • Expertise
  • Knowledge
  • Search
  • FR Menu
  • Search Mobile
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
View all
Practices
Corporate Litigation Regulatory Tax View all
Industries
Energy Infrastructure Mining Private Equity & Investment Funds View all
Advisory
Crisis & Risk Management Public Policy
View Client Work
International Experience
Insights News Events Subscribe
Arbitration Angle Artificial Intelligence Insights Business Law Talks Podcast Class Actions: Looking Forward Class Action Quick Takes
Economic Outlook New Energy Economy Series Quarterly Fintech Insights Quarterly M&A Insights Sustainability & the CIO
People
Offices
About
Practices
Industries
Advisory Services
Client Work
Insights
News
Events
Careers
Law Students
Alumni
Payments
Search
Subscribe

Stay informed on the latest business and legal insights and events.

LinkedIn LinkedIn Twitter Twitter Vimeo Vimeo
 

Life Sciences

  • Download PDF
  • Key Contacts
  • Select Experience
  • Recent Recognition
  • Insights, News & Events
  • Related Services
  • Download PDF
  • Select Experience
  • Recent Recognition
  • Insights, News & Events
  • Related Services

We understand the unique challenges of the life sciences industry and the sophisticated needs of our innovative clients.

Clients trust us to provide practical advice at every stage: from securing capital and leveraging intellectual property to obtaining regulatory approvals, commercializing products, and defending against product liability and intellectual property claims. We also assist with executing strategic transactions and accessing public markets. 

What Clients Say

"The Bennett Jones team is incredibly responsive, as well as pragmatic in their approach to resolving issues."

Our national team delivers business-focused solutions and pragmatic legal support to companies across various industries, including pharmaceuticals, medical devices, biotechnology, environmental science, natural health products, food processing and more. Our clients range from global corporations to emerging start-ups, and everything in between. 

What Clients Say

"They are experienced and skilled to easily navigate complex issues and present context and options to our team."

How We Help

M&A and Capital Markets

Our leading Corporate group advises life sciences clients of all types on their key transactions, including strategic acquisitions and divestitures, joint ventures and investments, and the full range of public and private financing transactions. We work strategically and efficiently, guided by our clients’ business realities and risk tolerances. Discover more about our comprehensive services on our M&A and Capital Markets practice pages.

Intellectual Property

Our intellectual property lawyers, patent agents and trademark agents have deep technical and subject-matter expertise. We assist our clients in procuring and managing IP rights, and in commercial transactions to develop, buy, sell and license IP rights and technology. Members of our team are ranked as leading practitioners in international and national publications. Explore our IP practice and discover how our customized strategies can enhance the value of your innovations.

Product Regulation

We help manufacturers, distributors, importers and retailers of pharmaceuticals, medical devices, natural health products, cannabis and food with all legal aspects of the approval, manufacture, distribution, importation and sale of products in Canada. Our experienced team regularly advises and represents clients in their dealings with Health Canada, Canada’s Drug Agency, the pan-Canadian Pharmaceutical Alliance and provincial health authorities. Discover how our Product Regulation practice can guide your business through the complex regulatory landscape of bringing products to market in Canada.

Product Liability and Class Action Litigation

Our experienced national Product Liability team represents pharmaceutical and medical products manufacturers in multi-jurisdiction litigation, including class actions. We respond quickly and effectively to the legal and reputational challenges that arise from allegations of product defects or failures, regulatory non-compliance and recalls, and anticompetitive conduct or alleged misrepresentation. Learn how our Product Liability and Class Action Litigation teams can help you navigate complex disputes and manage legal and reputational risks.

Intellectual Property Litigation

Our lawyers represent life sciences clients in complex legal proceedings involving all types of IP rights. We represent pharmaceutical manufacturers in high-stake patent litigation, including under the Patented Medicines (Notice of Compliance) Regulations. Our IP litigation team brings together legal acumen, technical expertise and industry knowledge to safeguard your assets and secure favorable outcomes—inside and outside of the courtroom. Visit our IP Litigation page to find out how our experienced team can protect your interests in high-stakes IP disputes.

International Arbitration

Our International Arbitration team assists life sciences clients with resolving their most complex commercial disputes, such as multi-million dollar cross-border patent infringement disputes arising under license agreements and breach of contract disputes under international distribution agreements. We guide clients through the entire lifecycle of a dispute, draft robust dispute resolution clauses, represent them in the prosecution and defense of cases in international arbitration, and assist with the recognition and enforcement of awards. Our experienced lawyers work closely with clients to understand their business and develop a dispute strategy that will best protect them. Learn more about our team on our International Arbitration page.

Commercial Transactions and International Trade

Our Commercial Transactions and Intellectual Property Transactions teams advises, drafts and negotiates all types of commercial agreements for life sciences clients, including development and collaboration agreements, manufacturing, sourcing and distribution contracts, technology services and clinical trial agreements, and all types of IP licences.

Clients trust our International Trade & Investment group to navigate complex international trade rules by providing advice on compliance, including import and export controls, sanctions, customs valuation, tariff classification and origin. We help clients leverage free trade and investment protection agreements to expand their market access and protect their investments. Our advice extends to guidance on cross-border regulatory requirements, including product marking and labeling, and compliance with Canada’s deepening ethical supply chain requirements.

Competition & Antitrust

Clients rely on our proactive, pragmatic approach to help them manage complex merger reviews, foreign investment approvals and competition-related challenges in the life sciences sector.

Our Competition/Antitrust group includes the former Commissioner of the Competition Bureau, several former Bureau and Department of Justice officials, and some of Canada’s top competition counsel. We regularly represent life sciences companies in matters before the Bureau, providing expert litigation support and strategic advice. We have a unique and nuanced understanding of the Bureau’s priorities, enforcement practices and investigative approaches, which we leverage to protect our clients' interests.

Cannabis

We offer a business-focused approach to cannabis law, helping clients navigate industry complexities. Our national team blends legal advice with entrepreneurial thinking and leverages an extensive network of financing sources, government agencies and industry professionals. By acting as a single point of contact, we ensure seamless coordination and deliver customized solutions that position clients for success in the cannabis sector. Discover how our Cannabis Law team combines legal expertise with strategic insight to help life sciences clients unlock valuable business opportunities.

Key Contacts

  • Aaron E. Sonshine Aaron E. Sonshine, Partner
  • Dominique T. Hussey Dominique T. Hussey, Chief Executive Officer
  • Ian C. Michael Ian C. Michael, Partner
  • Vincent M. de Grandpré Vincent M. de Grandpré, Partner
  • Cheryl M. Woodin Cheryl M. Woodin, Partner
  • Related Lawyers

Select Experience

Corporate and Transactional Law
Litigation and Dispute Resolution
Intellectual Property and IP Litigation
Product Regulation, Competition and Trade

A syndicate of underwriters, co-led by Leede Jones Gable, in the C$8.1-million bought-deal public offering of units of Ventripoint Diagnostics

A.G.P./Alliance Global Partners in a US$30-million public offering of units pursuant to a prospectus supplement with Cybin

Bloom Burton and Haywood Securities in a US$150-million private placement of common shares of Cybin

Breathe Biomedical in its proposed listing on NASDAQ and the TSX

Briacell Therapeutics Corp., in its public offering of common shares for gross proceeds of USD$3,050,000

Briacell Therapeutics in the spin-out of BriaPro Therapeutics Corp

Concept Medical, a leading aesthetic medical clinic, in its acquisition by Functionalab Group and Dermapure.

Cantor Fitzgerald Canada Corporation in an up to US$35-million at-the-market equity program for the sale of common shares pursuant to an equity distribution agreement with Cybin

Corus Orthodontists Inc., one of North America’s largest orthodontic partner networks, in various corporate matters

Extendicare in its agreement to sell its retirement living operations comprised of 1,048 retirement living suites across eleven retirement communities in Ontario and Saskatchewan, to SiennaSabra for an aggregate purchase price of C$307.5-million

ICLS Dermatology, one of Canada's leading medical aesthetics clinics, in its acquisition by MedSpa Partners Inc.

Kensington Capital Partners and Kensington Private Equity Fund in the C$35-million acquisition and related financing through its portfolio company, Clearpoint Health Network, of the surgical and medical centres business of Centric Health Corporation, a TSX listed company, and subsequent reorganization of Clearpoint

Medicus Pharma in its recent Canadian listing, establishment of a US$50-million shelf prospectus with the Ontario Securities Commission, and proposed US listing

Medicus Pharma in its US IPO and NASDAQ-listing

Mimi's Rock in its C$30-million acquisition by FitLife Brands by way of plan of arrangement as well as ongoing corporate, M&A, securities, real estate and governance advice

MustGrow Biologics in connection with the filing of a base shelf prospectus relating to the offering for sale, from time to time, of common shares, warrants, units, debt securities, subscription receipts or any combination thereof for aggregate gross proceeds of up to C$40 million

Mustgrow Biologics in a joint venture with Bayer to develop sustainable organic biologicals in Europe, Asia Pacific, Middle East and Africa

MustGrow Biologics in its non-brokered private placement for gross proceeds of C$7.1 million

Northern Health Authority in the Mills Memorial Hospital Redevelopment Project

Northern Health Authority in the Stuart Lake Hospital Redevelopment Project serving Fort St. James and surrounding First Nations communities

Numinus Wellness in the establishment of a shelf prospectus for proceeds of C$150 million

Reunion Neuroscience in its acquisition and take-private transaction with MPM BioImpact

Skandinaviska Enskilda Banken AB as joint lead arranger and joint bookrunner in term loan facilities totalling C$385 million and C$125 million revolving credit facility made to a corporation in the medical technology industry

Solve FSHD Holdings as lead investor with Cambrian Biopharma in Vita Therapeutics' US$31-million Series B equity financing

Stifel Nicolaus Canada in the C$2.8-million overnight marketed offering of Mydecine Innovations Group

United Active Living in matters related to ownership and operations of assisting living housing projects

VIVO Cannabis Inc., a TSX-listed cannabis producer, in its $50 million all-equity business combination with MediPharm Labs Corp
A consortium of six provincial and three territorial governments in a C$32.5-billion resolution with the tobacco industry to recover the healthcare costs associated with smoking

Apotex in two class actions in British Columbia concerning alleged nitrosamine impurities in pharmaceutical products, including losartan and amitriptyline

Bard/Becton, Dickinson and Company and Davol in the defence of multiple class actions and more than 200 individual mass tort product liability actions relating to hernia mesh

Dr. Reddy's Laboratories Canada and Pharmascience in a proposed class action in the Federal Court alleging industry-wide price fixing and market allocation of generic drugs

Gore Medical in the defence of an individual hernia mesh matter

Namaste Laboratories, Dabur USA and Dabur International in proposed class proceedings in British Columbia and Québec alleging that chemical hair straightening products cause or increase the risk of uterine, ovarian and breast cancer, and fibroids, due to the alleged presence of endocrine-disrupting chemicals

Nature's Bounty in the defence of a class action related to its glucosamine products

Pharmascience in successfully defending nine class actions in four jurisdictions across Canada related to alleged impurities in pharmaceutical products

Amgen Canada in patent litigation brought by Alexion Pharmaceuticals, and in related patent impeachment proceedings, relating to SOLIRIS (eculizumab)

Amgen in five patent infringement actions involving six different patents initiated by plaintiffs Bayer and Regeneron Pharmaceuticals relating to the drug EYLEA

Amgen in a judicial review proceeding initiated by Bayer relating to the timing of listing patents on the patent register

Intellectual property strategy, prosecution and portfolio management for life sciences clients such as 48Hour Discovery, Alberta Glycomics Centre, Alberta Research Chemicals, Amgen, ANDE Corporation, Biological E Limited, Carmot Therapeutics, Curza Global, Eastern Virginia Medical School, Exelixis, Insilico Medicine IP Limited, Li Ka Shing Institute of Virology, Liven Proteins, Mirati Therapeutics, Rapid Infection Diagnostics, Sinoveda Canada, SolAeroMed, University of Alberta and Vitalixir (Beijing)

Champion Petfoods, maker of ORIJEN and ACANA, on the intellectual property aspects of its sale to an affiliate of Mars

A biotechnology company in its product liability matters in Canada

A global fashion and lifestyle retailer in providing regulatory advice related to the approval, sale and advertisement of cosmetics and medical devices consistent with the client's commercial goals

A multinational specialty biopharmaceutical company in providing regulatory advice related to its drug and medical device products. We routinely advise on licensing, packaging and labelling, distribution, advertising and sale requirements

Canadian competition counsel to Alere in its US$5.3-billion acquisition by Abbott Laboratories

Allergan regarding all competition law matters and filings in its acquisition by AbbVie for US$63 billion, named the Deal Awards 2020 Healthcare, Pharma & Biotech Deal of the Year

Seagen, as Canadian competition counsel, in its US$43-billion acquisition by Pfizer

Canadian counsel to St. Jude Medical regarding all competition law matters and filings in its acquisition by Abbott Laboratories for US$25 billion

Recent Recognition

Chambers Canada
Ranked in Life Sciences, Intellectual Property Litigation, International Trade/WTO, Competition/Antitrust, Corporate/M&A and Product Liability
Chambers Canada Awards

Named Class Action Law Firm of the Year

Canadian Legal Lexpert Directory

Most Frequently Recommended, Class Actions (Toronto); Corporate Commercial Law (Calgary); Corporate Finance & Securities (Calgary); Mergers & Acquisitions (Calgary); Litigation - Product Liability (Toronto)
Consistently Recommended, Class Actions (Calgary); Corporate Commercial Law (Toronto, Vancouver); Competition Law (Calgary, Toronto); Corporate Finance & Securities (Toronto); Intellectual Property (Calgary, Edmonton, Toronto); Mergers & Acquisitions (Toronto)
Repeatedly Recommended, Mergers & Acquisitions (Vancouver); Litigation - Product Liability (Calgary)

Chambers Global

Band 1, International Trade/WTO
Band 2, Corporate/M&A; Competition/Antitrust
Band 4, Capital Markets
Band 5, Intellectual Property

 

Legal 500 Canada
Ranked in Corporate/M&A, International Trade/WTO, Competition/Antitrust, Capital Markets and Intellectual Property

Insights, News & Events

Blog

BBHIC 2025: Key Insights From Canada’s Leading Healthcare Investment Conference

May 08, 2025
       

Client Work

Landmark C$32.5 Billion Resolution of Tobacco Litigation Approved by Ontario Court

March 14, 2025
       

Articles

Tobacco Industry Settles for C$32.5 Billion in Landmark Canadian Class Action

March 10, 2025
       

Related Services

Cannabis Law
Commercial Transactions
Intellectual Property Advisory
Intellectual Property Transactions
Restructuring & Insolvency
Capital Markets
Corporate Governance
Intellectual Property Law
Mergers & Acquisitions
Tax
Commercial Litigation
Employment Services
Intellectual Property Litigation
Product Regulation
Bennett Jones Centennial Footer
Bennett Jones Centennial Footer
About
  • Leadership
  • Diversity
  • Community
  • Innovation
  • Security
Offices
  • Calgary
  • Edmonton
  • Montréal
  • Ottawa
  • Toronto
  • Vancouver
  • New York
Connect
  • Insights
  • News
  • Events
  • Careers
  • Students
  • Alumni
Subscribe

Stay informed on the latest business and legal insights and events.

LinkedIn LinkedIn Twitter Twitter Vimeo Vimeo
© Bennett Jones LLP 2025. All rights reserved.
  • Privacy Policy
  • Disclaimer
  • Terms of Use
Logo Bennett Jones